Trial Profile
Pilot Study of the GLP-1 Agonist, Liraglutide, on Decreasing Parenteral Support Requirements in Short Bowel Patients.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Short bowel syndrome
- Focus Therapeutic Use
- Acronyms SLIPS
- 12 Aug 2020 Planned primary completion date changed from 30 Aug 2020 to 6 Aug 2020.
- 12 Aug 2020 Status changed from recruiting to withdrawn prior to enrolment.
- 15 Jan 2020 Status changed from not yet recruiting to recruiting.